XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Shareholders Equity (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended
Jun. 11, 2021
shares
Mar. 31, 2024
USD ($)
D
shares
Mar. 31, 2023
USD ($)
Jan. 31, 2024
Dec. 31, 2023
USD ($)
May 27, 2021
$ / shares
shares
Shareholders' Equity            
Conversion, threshold percentage of market price   95.00%        
Gain (loss) recognized for the change in liability | $   $ 5,679 $ 34,314      
5.10% senior notes due September 2023            
Shareholders' Equity            
Interest rate (as a percent)   5.10%        
0.75% senior exchangeable notes due January 2024            
Shareholders' Equity            
Interest rate (as a percent)   0.75%     0.75%  
5.75% senior notes due February 2025            
Shareholders' Equity            
Interest rate (as a percent)   5.75%   5.75% 5.75%  
7.25% senior notes due January 2026            
Shareholders' Equity            
Interest rate (as a percent)   7.25%        
Common share warrants            
Shareholders' Equity            
Number of warrants received per common share held           0.40
Number of warrants issued 3,200,000          
Number of business day notice period | D   20        
Fair value of outstanding warrants | $   $ 20,200     $ 25,900  
Warrants outstanding   2,500,000        
Common share warrants | Other, net            
Shareholders' Equity            
Gain (loss) recognized for the change in liability | $   $ 5,700 $ 34,300      
Common Shares            
Shareholders' Equity            
Aggregate number of shares issued from the exercise of warrants   1,100,000        
Number of shares which may be purchased by each right           1
Exercise price (in dollars per share) | $ / shares           $ 166.66667